Safety and efficacy of faecal microbiota transplantation by Anaerobic Cultivated Human Intestinal Microbiome (ACHIM) in patients with systemic sclerosis: study protocol for the randomised controlled phase II ReSScue trial

Safety and efficacy of faecal microbiota transplantation by Anaerobic Cultivated Human Intestinal Microbiome (ACHIM) in patients with systemic sclerosis: study protocol for the randomised controlled phase II ReSScue trial

Introduction In the multisystem inflammatory disorder systemic sclerosis (SSc), gastrointestinal tract (GIT) affliction is highly prevalent. There are no known disease modifying therapies and the negative impact is substantial. Aiming for a new therapeutic principle, and inspired by recent work show...

Full description

Bibliographic Details
Main Authors: Gunnstein Bakland, Elizabeth R Volkmann, Dinesh Khanna, Oliver Distler, Anna-Maria Hoffmann-Vold, Øyvind Midtvedt, Øyvind Molberg, Alvilde Dhainaut, Vikas K Sarna, Håvard H Fretheim, Imon Barua, Maylen N Carstens, Henriette Didriksen, Anne-Kristine Halse, Maiju Pesonen, Inge Olsen
Format: Article
Language:English
Published: BMJ Publishing Group 2021-06-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/11/6/e048541.full

Internet

https://bmjopen.bmj.com/content/11/6/e048541.full

Similar Items